Navigation Links
Northwestern to explore personalized medicine for scleroderma

CHICAGO --- Northwestern Medicine researchers have received two five-year grants totaling $953,000 from the National Institutes of Health's (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to study scleroderma, an autoimmune disease for which there currently is no cure. The grants will enable researchers at Northwestern to identify biomarkers for the disease, and are the first step in developing a national resource for investigators studying scleroderma.

Scleroderma, also known as systemic sclerosis, is a chronic autoimmune disease in which the body's immune system attacks itself. It causes progressive thickening and tightening (fibrosis) of the skin and also can lead to serious internal organ damage and, in some cases, death.

Scleroderma affects an estimated 300,000 people in the United States, most frequently young to middle-aged women.

"These are game-changing grants for scleroderma research," said John Varga, M.D., professor of medicine and of dermatology at Northwestern University Feinberg School of Medicine and a physician at Northwestern Memorial Hospital. "They will greatly accelerate research into understanding fibrosis and its causes, and will move us toward personalized medicine for this complex disease."

Northwestern is one of four sites, along with Boston University School of Medicine, Dartmouth School of Medicine and University of Pittsburgh Medical Center, to receive funding through the new NIH grants. Northwestern will serve as the lead institution for proteomics research a fairly new area of biological study among this group, and will explore biomarkers at the protein level. These grants mark the first time large-scale proteomics will be applied to scleroderma research.

Early identification of biomarkers would potentially permit the development of more targeted therapies, noted Monique Hinchcliff, M.D., co-investigator and assistant professor of medicine at Feinberg.

"These grants allow researchers to use advanced techniques to study a very large and geographically diverse patient population at the molecular level," Hinchcliff said.

Contact: Marla Paul
Northwestern University

Related medicine news :

1. Lung cancer patients are the centerpiece for Northwestern medicine quality of care study
2. Northwestern Memorial maintains top status in nursing hospital renewed for Nurse Magnet®
3. Northwestern Medicine multiple sclerosis program earns national designation
4. Explorers Bounty Puffed Fruit Snacks Helping Parents Battle Summer Obesity
5. Pittsburgh Neurosurgeons Explore Use of Drug that Illuminates Brain Tumor Cells To Guide Surgery
6. Unusual Place to Find Peace, Bliss and Explore Life's Mysteries
7. GE Healthcare, Intel and Mayo Clinic explore new models of health care delivery
8. DSM Personalized Nutrition Webinar Explores Benefits of Nutrition for Employee Health
9. Explore, Love, Happiness, Life Purpose, and Destiny with World Renowned Yogi and Mystic, Sadhguru
10. Lung cancer research explores the effects of patient attitudes on patient outcomes
11. Top Scientists Explore the Origin of Life in Annual Lasker Lecture at Scripps Research Institute Florida Campus
Post Your Comments:
(Date:11/25/2015)... Cleveland, OH (PRWEB) , ... November 25, 2015 , ... ... dental implants in Cleveland, OH , are invited to attend Dr. Mark Iacobelli’s Advanced ... 5th this year in Cleveland, OH. , As the co-founders of Advanced Implant ...
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law ... successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys ... Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, Adcock ...
(Date:11/25/2015)... ... ... SCOTTSDALE, AZ) - Today, Dr. Todd C. Hobgood ... non-surgical treatments, announced the expansion of his private practice capabilities with the grand ... trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves the ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... ... November 25, 2015 , ... Castlewood ... people struggling with eating disorders as a result of the $20,000 raised at ... held at Fox Run Golf Club in Eureka, will help individuals who otherwise ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
(Date:11/25/2015)... Kitov Pharma ceuticals ... biopharmaceutical company focused on the development of therapeutic candidates ... announced the closing of its previously announced underwritten public ... each representing 20 ordinary shares of the Company, and ... and warrants were issued in a fixed combination of ...
(Date:11/25/2015)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer of ... Antonius Schuh, Ph.D., is scheduled to present a corporate ... Healthcare Conference. th Annual Piper Jaffray ... New York on Tuesday, December ... be available for one-on-one meetings during the conference. The ...
Breaking Medicine Technology: